medRxivGenetic & Genomic MedicinePreprint
Differential causative effects of germline pathogenic variants in MUTYH and PALB2 in a patient with colorectal polyposis and breast cancer
José Camacho ValenzuelaiD, Dylan PelletieriD, Paz P PolakiD, Lili FuiD, Nancy HameliD, Céline DomecqiD, Afrida AhmediD, Carla Daniela Robles‐EspinozaiD, William David FoulkesiD
Abstract
PurposePatients carrying Germline Pathogenic Variants (GPVs) in multiple cancer susceptibility genes (CSGs) can be described within the context of Multi-locus Inherited Neoplasia Allele Syndrome (MINAS). The role of each GPV is typically interpreted based on clinical phenotypes. Here, we used tumor sequencing, particularly mutational signatures, to investigate the contribution of GPVs in MUTYH and PALB2 to colorectal polyposis and breast cancer in a single patient at a molecular level. MethodsWe analyzed tumor sequencing data, including mutational signatures and genomic scars, of a breast tumor and a colorectal polyp from a patient with biallelic GPVs in MUTYH and a heterozygous GPV in PALB2. ResultsThe colorectal polyp showed a dominant contribution of MUTYH-associated Base Excision Repair deficiency (BERd) mutational signatures, with no evidence of Homologous Recombination Repair Deficiency (HRD). In contrast, the breast tumor showed both MUTYH-driven BERd and HRD-associated signatures, including SBS3, ID6 and an elevated HRD score, despite the absence of a detectable second hit in PALB2. These findings suggest a differential contribution from the CSGs, with MUTYH contributing to both lesions and PALB2 contributing specifically to the breast tumor. The observed pattern does not align with the additive or synergistic models described in MINAS. ConclusionsOur study provides evidence that mutational signatures can elucidate the contribution of multiple CSGs to tumorigenesis within a single patient. These findings extend current interpretations of MINAS beyond additive or synergistic phenotypes, which may help to better understand tumor etiology, with potential clinical implications, including eligibility for targeted therapies.
- organism: human
- assay: whole-exome sequencing
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Germline haploinsufficiency for the base excision repair gene MUTYH causes mutational signature SBS18 in multiple tumour types, specifically leading to an increased risk of colorectal cancer
Kitty Sherwood, Juan J. Fernandez-Tajes, … Ian P.M. Tomlinson·medRxiv·Nov 20, 2025
- Adenomas from individuals with pathogenic biallelic variants in the MUTYH and NTHL1 genes demonstrate base excision repair tumour mutational signature profiles similar to colorectal cancers, expanding potential diagnostic and variant classification applications
Romy Walker, Jihoon Eric Joo, … Peter Georgeson·medRxiv·Aug 8, 2024
- Phenotype correlations with pathogenic DNA variants in the MUTYH gene
Monica Thet, John‐Paul Plazzer, … Finlay Macrae·medRxiv·May 15, 2024
- Unusual profile of germline genetic variants in unselected colorectal cancer patients from a high-prevalence region in Panama
Iván Landires, José Pinto-Llerena, … Virginia Núñez-Samudio·GenesPeer-reviewed·Jul 28, 2025
- A maternal germline mutator phenotype in a family affected by heritable colorectal cancer
Candice Young, Annabel C. Beichman, … Kelley Harris·GeneticsPeer-reviewed·Oct 15, 2024
- A comprehensive genomic framework for identifying genes predisposing to homologous recombination repair deficient breast cancer
José Camacho Valenzuela, Thibaut Matis, … William David Foulkes·medRxiv·Oct 22, 2025